--- title: The broader societal impact of Alzheimer's disease in the Netherlands description: Discover the societal impact of Alzheimer’s in the Netherlands and how new treatments can reduce care needs and costs while improving patient outcomes. image: https://health-ecore.com/hubfs/robina-weermeijer-IHfOpAzzjHM-unsplash-1-1.jpeg --- [Skip to the main content.](https://health-ecore.com/news/the-broader-societal-impact-of-alzheimers-disease#main-content) [![HE\_logo\_fc-35-1](https://health-ecore.com/hs-fs/hubfs/HE_logo_fc-35-1.png?width=1500&height=326&name=HE_logo_fc-35-1.png "HE_logo_fc-35-1")](https://health-ecore.com/) [![Health-Ecore](https://health-ecore.com/hs-fs/hubfs/HE_logo_fc-35.png?width=1772&height=385&name=HE_logo_fc-35.png "Health-Ecore")](https://health-ecore.com/) - [Home](https://health-ecore.com) - [About us](https://health-ecore.com/about-us) - Our work - [Scientific work](https://health-ecore.com/publications) - [RSV web app](https://health-ecore.com/news/rsv-vaccination-a-cost-effective-strategy-for-older-adults-in-the-netherlands) - [DRAIGON SLR app](https://slrmadraigon.apps.health-ecore.com/) - [Team](https://health-ecore.com/team) - [News](https://health-ecore.com/news) - [Contact](https://health-ecore.com/contact) Toggle Menu Toggle Menu - [Home](https://health-ecore.com) - [About us](https://health-ecore.com/about-us) - Our work - [Scientific work](https://health-ecore.com/publications) - [RSV web app](https://health-ecore.com/news/rsv-vaccination-a-cost-effective-strategy-for-older-adults-in-the-netherlands) - [DRAIGON SLR app](https://slrmadraigon.apps.health-ecore.com/) - [Team](https://health-ecore.com/team) - [News](https://health-ecore.com/news) - [Contact](https://health-ecore.com/contact) [Linkedin](https://www.linkedin.com/company/health-ecore/posts/?feedView=all) 2 min read # The broader societal impact of Alzheimer's disease in the Netherlands [![Picture of Simon van der Schans](https://app.hubspot.com/settings/avatar/9be45cf1daa01220a3267c98d955a2b7) Simon van der Schans](https://health-ecore.com/news/author/simon-van-der-schans) : Published September 18, 2025 Updated October 30, 2026 [Alzheimer's Disease](https://health-ecore.com/news/tag/alzheimers-disease) [Societal Cost-Benefit Analysis](https://health-ecore.com/news/tag/societal-cost-benefit-analysis) [Care Capacity](https://health-ecore.com/news/tag/care-capacity) ![The broader societal impact of Alzheimer's disease in the Netherlands](https://health-ecore.com/hs-fs/hubfs/robina-weermeijer-IHfOpAzzjHM-unsplash-1-1.jpeg?width=500&height=262&name=robina-weermeijer-IHfOpAzzjHM-unsplash-1-1.jpeg) Alzheimer’s disease is a high-burden, progressive disease. It has a substantial impact on patients, family, and friends, but also a broader societal impact. A large part can be attributed to the high care requirements of patients with this disease, in which they often rely on formal and informal care. They become more and more dependent on their carers when the disease progresses to a more advanced stage. In addition to the current care and treatment options, the introduction of amyloid-targeting therapies (ATTs) opens up a new type of treatment option. Health-Ecore performed a study to analyse the impact of Alzheimer’s disease on the formal and informal care requirements of patients, and the effect of slowing disease progression. Results show that treatment with ATTs can reduce both formal and informal care requirements and extend the time until the maximum care requirements are reached.    # The impact of Alzheimer's disease in the Netherlands ![nursing-home](https://health-ecore.com/hs-fs/hubfs/nursing-home.png?width=100&height=100&name=nursing-home.png) #### Impact on the patient Alzheimer's disease is a high-burden progressive disease. Patients experience severe cognitive decline and are dependent on formal and informal carers. ![nursing-home (1)](https://health-ecore.com/hs-fs/hubfs/nursing-home%20(1).png?width=100&height=100&name=nursing-home%20(1).png) #### Impact on carers The high care requirement of Alzheimer's disease patients requires many formal and informal carers. In the Netherlands, over 800.000 people are informal carers for someone with dementia1. ![accounting](https://health-ecore.com/hs-fs/hubfs/accounting.png?width=100&height=100&name=accounting.png) #### Impact on the healthcare budget The care requirement of Alzheimer's disease patients results in substantial healthcare costs. Alzheimer's disease is responsible for 10.6% the Dutch healthcare budget2. # Expected growth in the prevalence of patients with Alzheimer's disease in the Netherlands between 2020 and 20503 ![](https://health-ecore.com/hs-fs/hubfs/image-png-2.png?width=653&height=344&name=image-png-2.png)   # Our analysis Our model-based analysis applied principles of health economic modelling to assess the impact of slowing disease progression on the formal and informal care capacity for patients with Alzheimer's disease. By reducing the number of patients who reach more severe stages of the disease, overall patient health improves, resulting in a lower demand for care compared to untreated patients. Treatment with ATTs can reduce the maximum need for both formal and informal care by approximately 12-13%, and delay the point at which maximum formal care capacity is reached by 6 months. Although patients will eventually progress to more severe stages of Alzheimer's disease, they will remain in better health for a longer period. The availability of ATTs not only benefits patients by improving their health outcomes, but also reduces the significant emotional and physical burden experienced by formal and informal caregivers. These findings highlight the importance of continued investment in Alzheimer’s care in the Netherlands, to support patients, families, and caregivers, and to ensure the sustainability of the healthcare systems. The expected increase in demand for formal care, both for Alzheimer’s and other conditions, calls for structural changes to the future healthcare system to ensure it remains sustainable and accessible. Interventions that slow disease progression can play a crucial role in strengthening care capacity.   Download report    This study was funded by an unrestricted grant from Lilly Nederland.     1:  RIVM. Dementie | Infographic | Volksgezondheid en Zorg (2024). https://www.vzinfo.nl/dementie/infographic 2: Hendrikse B. Dementie prognoses gemeente. Vektis (2022 Sep). https://www.vektis.nl/nieuws/grote-toename-van-ouderen-met-dementie-verwacht 3: de Boer A, de Klerk M, Verbeek-Oudijk D, Plaisier I. Blijvende bron van zorg, Ontwikkelingen in het geven van informele hulp 2014-2019. Sociaal en Cultureel Planbureau (2020 Dec). https://www.scp.nl/publicaties/publicaties/2020/12/09/blijvende-bron-van-zorg   [![Sharing Insights at ISPOR Europe 2025: Our Poster Highlights](https://health-ecore.com/hubfs/Afbeelding%20van%20WhatsApp%20op%202025-11-03%20om%2015-38-48_f1ed7b46k.jpeg)](https://health-ecore.com/news/ispor25-posters) #### [Sharing Insights at ISPOR Europe 2025: Our Poster Highlights](https://health-ecore.com/news/ispor25-posters) [![Picture of Florian Zeevat](https://app.hubspot.com/settings/avatar/73887c1c8e359a90139f5bcfb08aae22) Florian Zeevat](https://health-ecore.com/news/author/florian-zeevat) : 6 November 2025, 13:33:44 CET Join Health-Ecore at ISPOR Europe 2025 in Glasgow to explore HEOR research on prevention, obesity, Alzheimer’s, and informal care. [Collaboration](https://health-ecore.com/news/tag/collaboration) [Health Policy](https://health-ecore.com/news/tag/health-policy) [Health Solutions](https://health-ecore.com/news/tag/health-solutions) [conference](https://health-ecore.com/news/tag/conference) [HEOR](https://health-ecore.com/news/tag/heor) [Read More](https://health-ecore.com/news/ispor25-posters) [![What Delayed RSV Vaccination Is Costing the Netherlands](https://health-ecore.com/hubfs/rsv-1.jpeg)](https://health-ecore.com/news/what-delayed-rsv-vaccination-costs-the-netherlands) #### [What Delayed RSV Vaccination Is Costing the Netherlands](https://health-ecore.com/news/what-delayed-rsv-vaccination-costs-the-netherlands) [![Picture of Simon van der Pol](https://app.hubspot.com/settings/avatar/6076bb0cafb0b64e016c0b629cc901de) Simon van der Pol](https://health-ecore.com/news/author/simon-van-der-pol) : 2 June 2026, 14:06:53 CEST Delays in RSV vaccination for older adults in the Netherlands have led to significant hospital admissions and economic losses, highlighting urgent... [RSV](https://health-ecore.com/news/tag/rsv) [Societal Cost-Benefit Analysis](https://health-ecore.com/news/tag/societal-cost-benefit-analysis) [Vaccination](https://health-ecore.com/news/tag/vaccination) [Read More](https://health-ecore.com/news/what-delayed-rsv-vaccination-costs-the-netherlands) [![Health-Ecore and Pharma & Health Policy Hub Announce Strategic Partnership](https://health-ecore.com/hubfs/antoine-schibler-KF3Ty-K6NVA-unsplash.jpeg)](https://health-ecore.com/news/health-ecore-and-pharma-health-policy-hub-announce-partnership-to-drive-sustainable-impact-in-healthcare) #### [Health-Ecore and Pharma & Health Policy Hub Announce Strategic Partnership](https://health-ecore.com/news/health-ecore-and-pharma-health-policy-hub-announce-partnership-to-drive-sustainable-impact-in-healthcare) [![Picture of Tanja Fens](https://health-ecore.com/hs-fs/hubfs/Screenshot%202025-10-10%20at%2015.26.13.png?width=30&name=Screenshot%202025-10-10%20at%2015.26.13.png) Tanja Fens](https://health-ecore.com/news/author/tanja-fens) : 10 October 2025, 15:28:23 CEST Health-Ecore and the Pharma & Health Policy Hub have entered into a strategic partnership to advance research, provide expert advisory services, and... [Partnership](https://health-ecore.com/news/tag/partnership) [Collaboration](https://health-ecore.com/news/tag/collaboration) [Health Policy](https://health-ecore.com/news/tag/health-policy) [Sustainable Healthcare](https://health-ecore.com/news/tag/sustainable-healthcare) [Read More](https://health-ecore.com/news/health-ecore-and-pharma-health-policy-hub-announce-partnership-to-drive-sustainable-impact-in-healthcare) [![Facilitating Investments in Obesity Prevention and Treatments](https://health-ecore.com/hubfs/ECO%202026-1-1.jpeg)](https://health-ecore.com/news/facilitating-investments-in-obesity-prevention-and-treatments-in-the-netherlands) #### [Facilitating Investments in Obesity Prevention and Treatments](https://health-ecore.com/news/facilitating-investments-in-obesity-prevention-and-treatments-in-the-netherlands) [![Picture of Bart Slob](https://app.hubspot.com/settings/avatar/d41d8cd98f00b204e9800998ecf8427e) Bart Slob](https://health-ecore.com/news/author/bart-slob) : 13 May 2026, 14:10:39 CEST Societal costs of overweight and obesity in the Netherlands reach €650B by 2050. Our analysis shows investing in prevention and treatment pays off. [Societal Cost-Benefit Analysis](https://health-ecore.com/news/tag/societal-cost-benefit-analysis) [Obesity](https://health-ecore.com/news/tag/obesity) [Read More](https://health-ecore.com/news/facilitating-investments-in-obesity-prevention-and-treatments-in-the-netherlands) ![HE\_Invest\_Innovate\_Implement-39](https://health-ecore.com/hs-fs/hubfs/HE_Invest_Innovate_Implement-39.png?width=500&height=36&name=HE_Invest_Innovate_Implement-39.png)   - [Contact details](https://health-ecore.com/contact) - [Privacy policy](https://health-ecore.com/privacy-policy) - [LinkedIn policy](https://health-ecore.com/linkedin-rules) © 2026 Health-Ecore B.V. [Linkedin](https://www.linkedin.com/company/health-ecore/posts/?feedView=all) [GitHub](https://github.com/Health-Ecore) Chamber of Commerce: 72059419 | Tax registration: NL 858968447 B01 Return to top ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "Simon van der Schans", "url" : "https://health-ecore.com/news/author/simon-van-der-schans" }, "dateModified" : "2026-10-30T08:57:00.163Z", "datePublished" : "2025-09-18T12:57:30.000Z", "headline" : "The broader societal impact of Alzheimer's disease in the Netherlands", "image" : [ "https://health-ecore.com/hubfs/robina-weermeijer-IHfOpAzzjHM-unsplash-1-1.jpeg" ], "mainEntityOfPage" : { "@id" : "https://health-ecore.com/news/the-broader-societal-impact-of-alzheimers-disease", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://health-ecore.com/hubfs/HE_logo_fc-35.png" }, "name" : "Health-Ecore B.V." } } ``` ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : [ { "@type" : "Person", "name" : "Simon van der Schans", "url" : "https://health-ecore.com/news/author/simon-van-der-schans" } ], "dateModified" : "2026-10-30T08:57:00Z", "datePublished" : "2025-09-18T12:57:30Z", "description" : "Discover the societal impact of Alzheimer’s in the Netherlands and how new treatments can reduce care needs and costs while improving patient outcomes.", "headline" : "The broader societal impact of Alzheimer's disease in the Netherlands", "image" : [ "https://26748615.fs1.hubspotusercontent-eu1.net/hubfs/26748615/robina-weermeijer-IHfOpAzzjHM-unsplash-1-1.jpeg" ], "inLanguage" : "en", "keywords" : "Alzheimer's Disease, Societal Cost-Benefit Analysis, Care Capacity", "mainEntityOfPage" : { "@id" : "https://health-ecore.com/news/the-broader-societal-impact-of-alzheimers-disease", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "name" : "Health-Ecore B.V." } } ```